Literature DB >> 17125580

Presentation of first branchial cleft anomalies: the Sheffield experience.

M Martinez Del Pero1, S Majumdar, N Bateman, P D Bull.   

Abstract

Abnormalities of the first branchial cleft are rare. They may present with a cutaneous defect in the neck, parotid region, external auditory meatus or peri-auricular area, or with inflammatory or infective lesions at these sites. A retrospective case note review of the patients treated by the senior author is presented. This group consisted of 18 patients and represents the largest published UK series to date. Eleven patients (65 per cent) had undergone incomplete surgery prior to referral. Over half the patients had a clinically apparent lesion in relation to the external auditory meatus. There was a variable relationship between the tract and the facial nerve, which was identified at surgery in 15 cases. These findings are consistent with those of previously published series. Clinicians should keep this diagnosis in mind when assessing patients with infected lesions in the neck and parotid area. Surgeons should be familiar with parotid surgery, in children where appropriate, and be prepared to expose the facial nerve before embarking on the surgical management of these lesions.

Entities:  

Mesh:

Year:  2006        PMID: 17125580     DOI: 10.1017/S0022215106004373

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  3 in total

1.  The treatment for the first branchial cleft anomalies in children.

Authors:  Wei Liu; Min Chen; Jinsheng Hao; Yang Yang; Jie Zhang; Xin Ni
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-20       Impact factor: 2.503

2.  Clinical analysis of first branchial cleft anomalies in children.

Authors:  Wei Liu; Bing Liu; Min Chen; Jinsheng Hao; Yang Yang; Jie Zhang
Journal:  Pediatr Investig       Date:  2018-10-17

3.  First branchial cleft anomalies: presentation, variability and safe surgical management.

Authors:  Emad A Magdy; Yasmine A Ashram
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-11-29       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.